Body Moisturisers

SVR Laboratoire Xerial Psoriasis DM Medical Device Product for Psoriasis 200ml

Medical device for the treatment of psoriasis symptoms.

PSORIASIS XERIAL DM, a medical device for the treatment of psoriasis symptoms: plaques, scales, itching, redness. Thanks to its targeted...

Medical device for the treatment of psoriasis symptoms.

PSORIASIS XERIAL DM, a medical device for the treatment of psoriasis symptoms: plaques, scales, itching, redness. Thanks to its targeted keratolytic action, it reduces scaly plaques and eliminates the thickness of red and hardened areas, for smoother and soothing skin. Its intense moisturizing formula...

See full description See full description
19 00
Delivery by Tue, 11 Aug
14,00 €   shipping cost
Sent from Greece
From Pharmastation 5.0 (4)
Greece
3 pieces
See Body Skin Care on the page of Pharmastation

Description

Description

Medical device for the treatment of psoriasis symptoms.

PSORIASIS XERIAL DM, a medical device for the treatment of psoriasis symptoms: plaques, scales, itching, redness. Thanks to its targeted keratolytic action, it reduces scaly plaques and eliminates the thickness of red and hardened areas, for smoother and soothing skin. Its intense moisturizing formula relieves itching and reduces redness.

Benefits

DESIGNED FOR The treatment of psoriasis symptoms: plaques, scales, itching, redness. 

ADULTS FILM-FORMING CREAM TEXTURE Protects the skin, does not leave greasiness and does not stick, allowing you to dress immediately. 

DERMATOLOGICALLY TESTED On patients with psoriasis plaques. 

[CHILDREN FROM 3 YEARS OLD, ADULTS] Suitable for pregnant and breastfeeding women. 

[COOL TEXTURE, SOFT FINISH] Its cool texture combined with panthenol soothes the feeling of tightness and itching. Enriched with plant oils and butters, this lotion applies easily and wraps the skin without sticking. [DISCREET FRAGRANCE] 

[NATURAL FORMULA] 85% ingredients of natural origin.

IN 14 DAYS

• -27% scales

 AFTER 30 DAYS 

• -23% redness

 • +19% improvement of the plaque (total PSI score)

• 96% of patients stated that the film-forming texture spread easily

 1- Mammone, T., Gan, D., Fthenakis, C.; Marenus, K. The Effect of N-Acetyl-Glucosamine on Stratum Corneum Dequamation and Water Content in Human Skin. J. Cosmet. Sci. 2009, 60, 423–428. 

2- Multicenter (inactive center 1), randomized, double-blind, placebo-controlled clinical study on 30 patients with 2 psoriasis plaques (≈ 20 cm², at least 15 cm apart), in two separate phases with application of XERIAL DM Psoriasis or placebo twice daily on the psoriasis plaques for 30 days for phase 1 and for 28 days for phase 2 separately with treatment with calcipotriol and betamethasone (dermocorticosteroid). Clinical evaluation report dated 09/11/2021 no. 03-DM-2018 - ID-RCB number 2018-A03297-48. Evaluation of total PSI score and individual scores of scaling and roughness at 14 and 30 days (phase 1): PSI: n=30, mean (D0) = 7.50±1.22, mean (D14) = 6.10±1.75 (p<0.001), significant difference versus placebo, Scaling n=30, mean (D0) = 2.57±0.61, mean (D14): 1.87±0.90 (p<0.001), significant difference versus placebo. Redness n=30, mean (D0) = 2.60±0.50, mean (D30): 2.00±0.79 (p <0.001), significant difference versus placebo. Tolerance results: 42.4% of patients experienced a total of 24 mild to moderate adverse events, of which 13 were possibly related to the study products: 9 related to XERIAL DM PSORIASIS and 4 related to PLACEBO. These adverse events were: stinging (9%), itching (15%) and burning sensation (3%). All related adverse events were local and resolved before study completion. 

3- Multicenter (inactive center 1), randomized, double-blind, placebo-controlled clinical study on 30 patients with 2 psoriasis plaques (≈ 20 cm², at least 15 cm apart), in two separate phases with application of XERIAL DM Psoriasis or placebo twice daily on the psoriasis plaques for 30 days for phase 1 and for 28 days for phase 2 separately with treatment with calcipotriol and betamethasone (dermocorticosteroid). Clinical evaluation report dated 09/11/2021 no. 03-DM-2018 - ID-RCB number 2018-A03297-48. 7-day self-assessment (phase 2). 4- France Psoriasis.

 [RECYCLABILITY AND SORTING] Environmental properties and features: fully recyclable packaging. Contains at least 32% recycled material. Sorting instructions may vary locally. 

Instructions for Use

DAILY USE FOR 30 DAYS Apply twice a day in a thick layer on clean and dry face and body, on affected areas, on movable areas, on joints. Apply directly to psoriasis lesions. It can be used alternately with dermocorticosteroids. Do not use for more than 30 days.

ADVICE FROM THE LABORATORY AND THE DERMATOLOGIST

During the shower:

• Prefer taking a shower rather than a bath, avoiding very hot water (<36°C).

• Do not stay in the shower or bath for too long (do not exceed 20 minutes).

• Prefer cleansing products without soaps such as Huile Lavante Topialyse (with fragrance) or Baume Lavant Topialyse (fragrance-free). ‍ After the shower:

• Pat your skin dry with a soft towel

• On psoriatic lesions, on clean and dry skin: apply Psoriasis Xerial DM

• On the rest of the body, on skin without lesions: use your usual moisturizing cosmetic cream. Xerial 10 Lait moisturizes and smooths the skin.

Although psoriasis causes itching, it is important to try not to remove psoriatic lesions. Scratching for 5 minutes can activate psoriasis for 3 weeks4. Stress is one of the factors that may promote the appearance of psoriatic lesions. However, it is not the direct cause itself. Therefore, it is important to avoid stressful situations, and when you feel overwhelmed by stress, have solutions to calm down, such as meditation, relaxation.

Manufacturer

See full description

Specifications

Specifications

Dimensions

Concern
Moisturizing
Texture
Cream
With Fragrance
Yes

Quantity

Total Volume
200 ml

Important information

Specifications are collected from official manufacturer websites. Please verify the specifications before proceeding with your final purchase. If you notice any problem you can report it here.

See all specifications

Description & Specifications

Medical device for the treatment of psoriasis symptoms.

PSORIASIS XERIAL DM, a medical device for the treatment of psoriasis symptoms: plaques, scales, itching, redness. Thanks to its targeted keratolytic action, it reduces scaly plaques and eliminates the thickness of red and hardened areas, for smoother and soothing skin. Its intense moisturizing formula relieves itching and reduces redness.

Benefits

DESIGNED FOR The treatment of psoriasis symptoms: plaques, scales, itching, redness. 

ADULTS FILM-FORMING CREAM TEXTURE Protects the skin, does not leave greasiness and does not stick, allowing you to dress immediately. 

DERMATOLOGICALLY TESTED On patients with psoriasis plaques. 

[CHILDREN FROM 3 YEARS OLD, ADULTS] Suitable for pregnant and breastfeeding women. 

[COOL TEXTURE, SOFT FINISH] Its cool texture combined with panthenol soothes the feeling of tightness and itching. Enriched with plant oils and butters, this lotion applies easily and wraps the skin without sticking. [DISCREET FRAGRANCE] 

[NATURAL FORMULA] 85% ingredients of natural origin.

IN 14 DAYS

• -27% scales

 AFTER 30 DAYS 

• -23% redness

 • +19% improvement of the plaque (total PSI score)

• 96% of patients stated that the film-forming texture spread easily

 1- Mammone, T., Gan, D., Fthenakis, C.; Marenus, K. The Effect of N-Acetyl-Glucosamine on Stratum Corneum Dequamation and Water Content in Human Skin. J. Cosmet. Sci. 2009, 60, 423–428. 

2- Multicenter (inactive center 1), randomized, double-blind, placebo-controlled clinical study on 30 patients with 2 psoriasis plaques (≈ 20 cm², at least 15 cm apart), in two separate phases with application of XERIAL DM Psoriasis or placebo twice daily on the psoriasis plaques for 30 days for phase 1 and for 28 days for phase 2 separately with treatment with calcipotriol and betamethasone (dermocorticosteroid). Clinical evaluation report dated 09/11/2021 no. 03-DM-2018 - ID-RCB number 2018-A03297-48. Evaluation of total PSI score and individual scores of scaling and roughness at 14 and 30 days (phase 1): PSI: n=30, mean (D0) = 7.50±1.22, mean (D14) = 6.10±1.75 (p<0.001), significant difference versus placebo, Scaling n=30, mean (D0) = 2.57±0.61, mean (D14): 1.87±0.90 (p<0.001), significant difference versus placebo. Redness n=30, mean (D0) = 2.60±0.50, mean (D30): 2.00±0.79 (p <0.001), significant difference versus placebo. Tolerance results: 42.4% of patients experienced a total of 24 mild to moderate adverse events, of which 13 were possibly related to the study products: 9 related to XERIAL DM PSORIASIS and 4 related to PLACEBO. These adverse events were: stinging (9%), itching (15%) and burning sensation (3%). All related adverse events were local and resolved before study completion. 

3- Multicenter (inactive center 1), randomized, double-blind, placebo-controlled clinical study on 30 patients with 2 psoriasis plaques (≈ 20 cm², at least 15 cm apart), in two separate phases with application of XERIAL DM Psoriasis or placebo twice daily on the psoriasis plaques for 30 days for phase 1 and for 28 days for phase 2 separately with treatment with calcipotriol and betamethasone (dermocorticosteroid). Clinical evaluation report dated 09/11/2021 no. 03-DM-2018 - ID-RCB number 2018-A03297-48. 7-day self-assessment (phase 2). 4- France Psoriasis.

 [RECYCLABILITY AND SORTING] Environmental properties and features: fully recyclable packaging. Contains at least 32% recycled material. Sorting instructions may vary locally. 

Instructions for Use

DAILY USE FOR 30 DAYS Apply twice a day in a thick layer on clean and dry face and body, on affected areas, on movable areas, on joints. Apply directly to psoriasis lesions. It can be used alternately with dermocorticosteroids. Do not use for more than 30 days.

ADVICE FROM THE LABORATORY AND THE DERMATOLOGIST

During the shower:

• Prefer taking a shower rather than a bath, avoiding very hot water (<36°C).

• Do not stay in the shower or bath for too long (do not exceed 20 minutes).

• Prefer cleansing products without soaps such as Huile Lavante Topialyse (with fragrance) or Baume Lavant Topialyse (fragrance-free). ‍ After the shower:

• Pat your skin dry with a soft towel

• On psoriatic lesions, on clean and dry skin: apply Psoriasis Xerial DM

• On the rest of the body, on skin without lesions: use your usual moisturizing cosmetic cream. Xerial 10 Lait moisturizes and smooths the skin.

Although psoriasis causes itching, it is important to try not to remove psoriatic lesions. Scratching for 5 minutes can activate psoriasis for 3 weeks4. Stress is one of the factors that may promote the appearance of psoriatic lesions. However, it is not the direct cause itself. Therefore, it is important to avoid stressful situations, and when you feel overwhelmed by stress, have solutions to calm down, such as meditation, relaxation.

Manufacturer

Dimensions

Concern
Moisturizing
Texture
Cream
With Fragrance
Yes

Quantity

Total Volume
200 ml

Important information

Specifications are collected from official manufacturer websites. Please verify the specifications before proceeding with your final purchase. If you notice any problem you can report it here.

19,00 €
14,00 €   shipping cost